rhHIP/PAP regulatory update

EMEA's Committee for Orphan Medicinal Products (COMP) issued a positive opinion to grant Orphan Drug designation for Alfact's rhHIP/PAP to treat acute liver failure. The recombinant human hepatocarcin...